Daniel F. Boyer

4.5k total citations
18 papers, 744 citations indexed

About

Daniel F. Boyer is a scholar working on Pathology and Forensic Medicine, Surgery and Oncology. According to data from OpenAlex, Daniel F. Boyer has authored 18 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Daniel F. Boyer's work include Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (4 papers) and Pancreatic function and diabetes (4 papers). Daniel F. Boyer is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (4 papers) and Pancreatic function and diabetes (4 papers). Daniel F. Boyer collaborates with scholars based in United States, Switzerland and Australia. Daniel F. Boyer's co-authors include Christopher V.E. Wright, Mark A. Magnuson, Fabrizio Thorel, Pedro L. Herrera, Harry Heimberg, Xiaobo Xu, Mark Van de Casteele, Fong Cheng Pan, Eric D. Bankaitis and Nathan J. Charles and has published in prestigious journals such as New England Journal of Medicine, Genes & Development and Blood.

In The Last Decade

Daniel F. Boyer

18 papers receiving 735 citations

Peers

Countries citing papers authored by Daniel F. Boyer

Since Specialization

Citations

This map shows the geographic impact of Daniel F. Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. Boyer more than expected).

Fields of papers citing papers by Daniel F. Boyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel F. Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. Boyer. The network helps show where Daniel F. Boyer may publish in the future.

Co-authorship network of co-authors of Daniel F. Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. Boyer. A scholar is included among the top collaborators of Daniel F. Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. Boyer. Daniel F. Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Fibrin-associated large B-cell lymphoma shows frequent mutations related to immune surveillance and PTEN 2023 ·Blood ·Daniel F. Boyer, Anamarija M. Perry, (unknown), (unknown), Aimin Li, Ryan S. Jackson, Lorinda Soma, Weiwei Zhang, Joo Y. Song	3
2	Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts 2021 ·Leukemia Research ·(unknown), Anthony J. Perissinotti, Lydia L. Benitez, Daniel F. Boyer, Winston Lee, Patrick W. Burke, Kristen Pettit, Dale L. Bixby, Bernard L. Marini	3
3	Patch/plaque mycosis‐fungoides‐like presentations of DUSP22‐translocated T‐cell lymphomas 2021 ·Journal of Cutaneous Pathology ·(unknown), (unknown), (unknown), Kiyanna Williams, Lori Lowe, Daniel F. Boyer, Ryan A. Wilcox, Trilokraj Tejasvi, Alexandra C. Hristov	7
4	Cutaneous follicle center lymphomas with plasmacytic differentiation 2020 ·Journal of Cutaneous Pathology ·Stephanie L. Skala, Paul W. Harms, Douglas R. Fullen, Noah A. Brown, Trilokraj Tejasvi, Ryan A. Wilcox, Daniel F. Boyer, Alexandra C. Hristov	1
5	A Phase 2 Study with Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma with Upfront Daratumumab-Based Therapy 2019 ·Blood ·(unknown), Philip S. Boonstra, Daniel F. Boyer, Larry D. Anderson, Brea Lipe, (unknown), Erica Campagnaro, Matthew J. Pianko, Moshe Talpaz	2
6	Primary Cutaneous Composite Lymphomas 2018 ·Archives of Pathology & Laboratory Medicine ·(unknown), Daniel F. Boyer, Alexandra C. Hristov	4
7	Fibrin-associated EBV-positive Large B-Cell Lymphoma 2017 ·The American Journal of Surgical Pathology ·Daniel F. Boyer, Penelope McKelvie, Laurence de Leval, Kerstin L. Edlefsen, Young-Hyeh Ko, (unknown), Alexandra E. Kovach, Aneal S. Masih, (unknown), Lawrence M. Weiss, Alan K. Meeker, Valentina Nardi, Maryknoll Palisoc, Lina Shao, Stefania Pittaluga, Judith A. Ferry, Nancy L. Harris, Aliyah R. Sohani	65
8	Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls 2017 ·Archives of Pathology & Laboratory Medicine ·Nathan J. Charles, Daniel F. Boyer	39
9	Myeloid leukemia associated with Down syndrome 2017 ·Blood ·Caroline E. Talsma, Daniel F. Boyer	2
10	The immunophenotypic spectrum of primary mediastinal large B‐cell lymphoma reveals prognostic biomarkers associated with outcome 2016 ·American Journal of Hematology ·Jacob R. Bledsoe, Robert Redd, Robert P. Hasserjian, Jacob D. Soumerai, (unknown), Daniel F. Boyer, Judith A. Ferry, Lawrence Zukerberg, Nancy L. Harris, Jeremy S. Abramson, Aliyah R. Sohani	35
11	Blood and Bone Marrow Evaluation for Eosinophilia 2016 ·Archives of Pathology & Laboratory Medicine ·Daniel F. Boyer	12
12	Peripheral T-cell Lymphomas With Cytotoxic Phenotype in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2014 ·The American Journal of Surgical Pathology ·Daniel F. Boyer, Neal I. Lindeman, Nancy L. Harris, Judith A. Ferry	19
13	The Absolute Lymphocyte to Monocyte Ratio at Diagnosis Further Stratifies Survival Based on Cell of Origin in Diffuse Large B-Cell Lymphoma 2014 ·Blood ·Sumana Devata, (unknown), (unknown), (unknown), Daniel F. Boyer, Megan S. Lim, Nathanael G. Bailey, Ryan A. Wilcox	1
14	Case 38-2013 2013 ·New England Journal of Medicine ·Alaka Ray, Victorine V. Muse, Daniel F. Boyer	6
15	Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration 2013 ·Development ·Fong Cheng Pan, Eric D. Bankaitis, Daniel F. Boyer, Xiaobo Xu, Mark Van de Casteele, Mark A. Magnuson, Harry Heimberg, Christopher V.E. Wright	226
16	Context-specific α-to-β-cell reprogramming by forced Pdx1 expression 2011 ·Genes & Development ·(unknown), Fabrizio Thorel, Daniel F. Boyer, Pedro L. Herrera, Christopher V.E. Wright	157
17	Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expression 2006 ·Developmental Biology ·Daniel F. Boyer, Yoshio Fujitani, Maureen Gannon, Alvin C. Powers, Roland Stein, Christopher V.E. Wright	29
18	Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation 2006 ·Genes & Development ·Yoshio Fujitani, (unknown), Daniel F. Boyer, Maureen Gannon, Yoshiya Kawaguchi, Michael Ray, Masakazu Shiota, Roland Stein, Mark A. Magnuson, Christopher V.E. Wright	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact